FesariusTherapeutics - the cutting-edge biotech start-up on a mission to revolutionize the world of regenerative medicine. We are dedicated to developing innovative tissue-engineered products to transform reconstructive and aesthetic surgery. Based upon technology spun-out from The Laboratory for Bioregenerative Medicine and Surgery at Weill Cornell Medicine, FesariusTherapeutics has developed DermiSphere, a revolutionary dermal regeneration template (DRT) for the management of wounds.
View Top Employees from FesariusTherapeutics| Website | http://www.fesariustherapeutics.com |
| Revenue | $1 million |
| Employees | 8 (8 on RocketReach) |
| Founded | 2015 |
| Address | 760 Parkside Ave, Brooklyn, New York 11226, US |
| Phone | (917) 589-4850 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services, Pharmaceuticals |
| Competitors | Atlanta Research Center, Prestige Clinical Research Center Inc, Research Foundation |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 6215 Companies, NAICS Code 62151 Companies |
Looking for a particular FesariusTherapeutics employee's phone or email?
FesariusTherapeutics Questions
The FesariusTherapeutics annual revenue was $1 million in 2024.
Tom Roueche is the President and Chief Executive Officer of FesariusTherapeutics.
8 people are employed at FesariusTherapeutics.
FesariusTherapeutics is based in Brooklyn, New York.
The NAICS codes for FesariusTherapeutics are [621, 62, 6215, 62151].
The SIC codes for FesariusTherapeutics are [80, 807].
Top FesariusTherapeutics Employees
-
15+
-
23
-
51
-
32
-
25
-
-
11
Related Companies
